Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Pharma
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
After disappointing earnings from Lilly last week, Novo Nordisk’s report on the performance of its GLP-1s Ozempic and Wegovy is more of a mixed bag.
Fraiser Kansteiner
Nov 6, 2024 2:34pm
After extended shortage, all Ozempic, Wegovy doses on tap in US
Oct 31, 2024 2:40pm
UK warns GLP-1s not for 'body beautiful picture for Instagram'
Oct 25, 2024 8:20am
Consumer groups urge FTC to block Novo Holdings' Catalent deal
Oct 18, 2024 10:20am
Novo settles with Mylan over potential Ozempic generic
Oct 7, 2024 9:18am
FDA removes Lilly's Mounjaro and Zepbound from its shortage list
Oct 3, 2024 11:22am
